CUSIP: 89853L203
Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
18,241,365
-
Share change
-
+11,289,715
-
Total reported value
-
$4,014,799
-
Put/Call ratio
-
118%
-
Price per share
-
$0.22
-
Number of holders
-
40
-
Value change
-
+$2,763,528
-
Number of buys
-
31
-
Number of sells
-
12
Quarterly Holders Quick Answers
What is CUSIP 89853L203?
CUSIP 89853L203 identifies TTOO - T2 BIOSYSTEMS INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2023
-
Previous quarter:
Q2 2023
Recent filing periods for CUSIP 89853L203:
Institutional Holders of T2 BIOSYSTEMS INC - COM NEW (TTOO) as of Q3 2023
As of 30 Sep 2023,
T2 BIOSYSTEMS INC - COM NEW (TTOO) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,241,365 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GSA CAPITAL PARTNERS LLP, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, Baader Bank Aktiengesellschaft, GROUP ONE TRADING, L.P., NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and TWO SIGMA SECURITIES, LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.